Mithra Pharmaceuticals S.A.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MITPF research report →
Price Chart
About the company
Mithra Pharmaceuticals S. A. , established in 1999 and headquartered in Liège, Belgium, is a pharmaceutical company dedicated to the global development, manufacturing, and marketing of advanced therapeutic solutions.
- CEO
- Christophe Marechal
- IPO
- 2020
- Employees
- 270
- HQ
- Liège, BE
Get TickerSpark's AI analysis on MITPF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $1.60B
- P/E
- -0.09
- Fwd P/E
- 38.60
- PEG
- -0.00
- P/S
- 0.36
- P/B
- -0.14
- EV/EBITDA
- -4.00
- Div Yield
- 0.00%
- Gross Margin
- 14.92%
- Op Margin
- -172.63%
- Net Margin
- -432.08%
- ROE
- 498.80%
- ROIC
- -32.14%
Latest fiscal year · YoY change
- Revenue
- $40.16M-40.1%
- Gross Profit
- $5.99M-83.1%
- Op Income
- $-69,321,000
- Net Income
- $-173,502,000-191.0%
- EPS
- $-2.51-105.7%
- OCF Growth
- +96.7%
- FCF Growth
- +97.6%
- 52W High
- $23.90
- 52W Low
- $6.75
- 50D MA
- $6.75
- 200D MA
- $6.75
- Beta
- 0.60
- RSI (14)
- 0
- Avg Volume
- 285
No earnings-call transcripts are available for MITPF yet.
- Free Float
- 97.6%
- Shares Outstanding
- 66.91M
- Float Shares
- 65.32M
Our MITPF coverage
Recent articles, reports, and earnings notes.
No research on MITPF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate MITPF report →